title: [Clinical efficiency of milrdonate in combined treatment of peripheral diabetic (sensory-motor) neuropathy].
authors.forename: M E
authors.initials: ME
authors.lastname: Statsenko
authors.forename: L V
authors.initials: LV
authors.lastname: Poletaeva
authors.forename: S V
authors.initials: SV
authors.lastname: Turkina
authors.forename: M A
authors.initials: MA
authors.lastname: Inozemtseva
authors.forename: A F
authors.initials: AF
authors.lastname: Apukhtin
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D008763:Methylhydrazines / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D008763:Methylhydrazines; C050147:3-(2,2,2-trimethylhydrazine)propionate